The terms “process-specific” and “generic” are commonly used in scientific publications and regulatory guidelines in reference to host cell protein (HCP) analysis of recombinant biopharmaceuticals.
In a typical bioprocessing run, the engineered cells produce a drug—but that’s not all. They also express and release host cell proteins (HCPs). Depending on the specific HCP and its concentration, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results